Mr Dallas John Carlson, PT - Physical Therapist in Cavalier, ND

Mr Dallas John Carlson, PT is a Physical Therapist based in Cavalier, North Dakota. Mr Dallas John Carlson is licensed to practice in North Dakota (license number 279) and his current practice location is 301 Mountain Street East, Cavalier, North Dakota. He can be reached at his office (for appointments etc.) via phone at (701) 265-6260.

NPI number for Mr Dallas John Carlson is 1114165164 and his current mailing address is P.o. Box 380, Cavalier, North Dakota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1114165164.

Contact Information

Mr Dallas John Carlson, PT
301 Mountain Street East,
Cavalier, ND 58220-0380
(701) 265-6260
(701) 265-8752



Healthcare Provider's Profile

Full NameMr Dallas John Carlson
GenderMale
SpecialityPhysical Therapist
Location301 Mountain Street East, Cavalier, North Dakota
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1114165164
  • Provider Enumeration Date: 01/29/2009
  • Last Update Date: 01/29/2009

Medical Identifiers

Medical identifiers for Mr Dallas John Carlson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1114165164NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist 279 (North Dakota)Primary
225100000XPhysical Therapist 522 (South Dakota)Secondary
225100000XPhysical Therapist 1456 (Minnesota)Secondary
225100000XPhysical Therapist 237 (Montana)Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Dallas John Carlson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mr Dallas John Carlson, PT
P.o. Box 380,
Cavalier, ND 58220-0380

Ph: (701) 265-6260
Mr Dallas John Carlson, PT
301 Mountain Street East,
Cavalier, ND 58220-0380

Ph: (701) 265-6260

News Archive

Imiquimod and fluorouracil emerge as effective weapons for treating superficial basal cell carcinomas

Basal cell carcinoma, a type of skin cancer, affects millions of people worldwide. While traditional treatment has been surgery and radiation, topical treatments in combination with surgery are showing more promise for patients with basal cell carcinoma.

Researchers uncover key factor for promoting wound healing after corneal injuries

In cases of severe ocular trauma involving the cornea, wound healing occurs following intervention, but at the cost of opaque scar tissue formation and damaged vision. Recent research has shown that mesenchymal stem cells (MSCs) — which can differentiate into a variety of cells, including bone, cartilage, muscle and fat cells — are capable of returning clarity to scarred corneas; however, the mechanisms by which this happens remained a mystery — until now.

Algorithm that analyzes MRI images could boost development of new arthritis therapies

An algorithm that analyses MRI images and automatically detects small changes in knee joints over time could be used in the development of new treatments for arthritis.

Baculovirus virion completely eliminates liver-stage parasites in mouse model

Currently, few antimalarial treatments exist that effectively kill liver-stage malaria parasites, which can lay dormant for months or years as in the case of Plasmodium vivax. Researchers from Kanazawa University have successfully demonstrated that administration of a baculovirus virion completely eliminates liver-stage parasites in a mouse model via BV-induced fast-acting innate immunity.

FDA approves an expanded indication for BYETTA injection

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.

Read more News

› Verified 7 days ago


Physical Therapist in Cavalier, ND

Ms. Sharon A Cummings, PHYSICAL THERAPIST
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 313 Division S., Cavalier, ND 58220
Phone: 701-265-4789    
Pembina Special Education Cooperative
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 106b Division Ave., Cavalier, ND 58220
Phone: 701-265-8080    
Alyssa Marie Rollness, D.P.T
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 301 Mountain St E, Cavalier, ND 58220
Phone: 701-265-6260    Fax: 701-265-6358

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.